Clinical Trial Update: Safety and Efficacy of Human Mesenchymal Stem Cells for Treatment of Liver Failure [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating the safety and efficacy of human mesenchymal stem cells for treating liver failure; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Failure

Drugs mentioned

• Human Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: Beijing 302 Hospital | Conditions: Liver Failure, Mesenchymal Stem Cells | Phase 1, Phase 2 | Status: UNKNOWN